Navigation Links
One More Drug to Fight Brain Cancer

The Eli Lilly and Company, a leading pharmaceutical manufacturer, has announced that the European Medicines Agency (EMEA) has granted enzastaurin,// an anti-cancer drug the status of an orphan drug.

(Orphan drug status gives the drug's manufacturer a seven-year right to exclusively market the compound. This protection of unpatentable orphan drugs encourages their development by greatly increasing their profitability.)

Enzastaurin, being developed by the Eli Lilly, is described as an investigational and multi-targeted oral cancer agent. It is particularly useful in a type of cancer called, non-Hodgkin's lymphoma. This type of cancer affects such regions as brain, bone-marrow and stomach.

Enrolment into a phase III clinical trial of enzastaurin is underway. Specifically, enzastaurin is being investigated as a maintenance therapy to prevent disease relapse.

Earlier the Lilly executives had said that the new drug could be useful in the treatment of recurring glioblastoma, a type of brain cancer.

Glioblastoma is part of the larger group of tumors that impact the central nervous system, known as gliomas. Patients with highly recurrent glioblastoma are usually at a more advanced stage of the disease. They may face altered brain function or death due to the tumor's rapid growth rate. At the moment there are very few adequate treatments for this disease.

Enzastaurin is the first targeted agent of Lilly Oncology to enter into late stage clinical development.It heralds a new phase of innovation for the group,it is stated.

'"/>




Page: 1

Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Smallpox Vaccine May Help Fight Cervical Cancer
5. Fight against E.coli
6. Red Wine Helps Fight Heart disease
7. Fish Oil Fights Arrhythmias, Sudden Death
8. SARS-Free Taiwan to Mark End Phase of Global Fight
9. Few Parents Help Kids Fight Acne
10. Common Cold Found to Fight Cancer
11. The Possibility Of Fighting HIV with Another Virus Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2017)... ... ... PracticeMatch, a company that provides online resources , job boards ... like nurse practitioners and physician assistants , will conduct its first ... The online career fairs will allow job seekers to connect with healthcare employers from ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... FCPX LUT ... Editors can quickly and easily add washed color grades to footage. A LUT ... LUT changes every pixel’s color to the corresponding color indicated by the table. This ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... widely recognized community involvement program serving the people of Michigan. The new initiative ... almost 120 years at the very forefront of animal protection and welfare by ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon Dr. James Veltmeyer, ... announced his candidacy for the 52nd Congressional District currently held by Representative Scott Peters. ... to this country at age eleven after suffering homelessness and hardship in a distant ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA Solutions, ... System has assisted multiple clients in successfully passing audits such as Office ... Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... Aug. 15, 2017  AOTI Inc. announced today that its fully ... has recently opened a New York City Office in ... its unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This ... Commission for Health Care (ACHC) under the company,s DMEPOS accreditation for ... ...
(Date:8/8/2017)... -- BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused ... for the second quarter ended June 30, 2017. ... and to date: ... Company,s lead project, BL-8040: Announced plans ... novel stem cell mobilization treatment for autologous bone-marrow transplantation ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve as ... tenure, Paul has served us in multiple leadership roles since ... in Jun. 2015 and has provided decisive, strategic leadership which ...
Breaking Medicine Technology: